Hengameh Goodarzi (Berlin / DE), Elke Lemke (Berlin / DE), Solvy Wolke (Berlin / DE), Frank Schwab (Berlin / DE), Beate Schlosser (Berlin / DE), Marco Paul (Berlin / DE), Annika Brodzinski (Berlin / DE), Giovanni-Battista Fucini (Berlin / DE), Britta Kohlmorgen (Berlin / DE), Sandra Jendrossek (Berlin / DE), Seven Aghdassi (Berlin / DE), Brar Piening (Berlin / DE), Christine Geffers (Berlin / DE), Miriam Wiese-Posselt (Berlin / DE), Luisa Denkel (Berlin / DE)
Introduction: Despite the widespread deployment of SARS-CoV-2 vaccines, breakthrough infections continue to pose challenges, particularly in healthcare settings. Nosocomial outbreaks remain a significant concern, warranting an in-depth investigation into the risk factors associated with SARS-CoV-2 acquisition among vaccinated individuals.
Goals: To identify risk factors for SARS-CoV-2 acquisition among vaccinated patients and healthcare providers in nosocomial outbreaks at Charité hospitals in Berlin, Germany, in 2022.
Materials & Methods: In this retrospective case-control study, we investigated SARS-CoV-2 acquisition in 114 nosocomial SARS-CoV-2 outbreaks notified to the healthcare authorities in 2022. Cases included 587 patients and 385 staff members who tested positive for SARS-CoV-2 during the outbreaks. Controls (not tested positive for SARS-CoV-2), were matched (1:1) to cases based on their patient/staff status and the time shared with a case on the ward 14 days before the case tested positive. All participants were fully vaccinated and completed a questionnaire regarding potential risk or protective factors for SARS-CoV-2 acquisition. Univariable analysis and multivariable logistic regression models were used.
Results: In total, 271 cases and 271 controls participated in the study. Our findings indicate that cases were more likely to be immunized > 3 months ago compared with controls (77.5% versus 68.6%, p= 0.02). Cases more often suffered from diabetes (15.2% versus 9.0%, p = 0.03) and less often had a previous SARS-CoV-2 infection (6.7 versus 15.7%, p < 0.01). Multivariable logistic models identified previous SARS-CoV-2 infection as an independent protective factor (OR=0.25, 95% CI: 0.11- 0.53). Independent risk factors were immunization > 3 months ago (OR=1.6, 95% CI: 1.05 – 2.7) and diabetes (OR =2.26, 95% CI: 1.13 – 4.72).
Summary: Our analyses suggest that certain primary diseases and an immunization older than 3 months were associated with increased risks of breakthrough infections in healthcare settings. However, a previous SARS-CoV-2 infection may have a protective effect. These findings represent preliminary results and warrant further validation.
Auf unserem Internetauftritt verwenden wir Cookies. Bei Cookies handelt es sich um kleine (Text-)Dateien, die auf Ihrem Endgerät (z.B. Smartphone, Notebook, Tablet, PC) angelegt und gespeichert werden. Einige dieser Cookies sind technisch notwendig um die Webseite zu betreiben, andere Cookies dienen dazu die Funktionalität der Webseite zu erweitern oder zu Marketingzwecken. Abgesehen von den technisch notwendigen Cookies, steht es Ihnen frei Cookies beim Besuch unserer Webseite zuzulassen oder nicht.